746 related articles for article (PubMed ID: 14599348)
1. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
[TBL] [Abstract][Full Text] [Related]
2. A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists.
Golla R; Seethala R
J Biomol Screen; 2002 Dec; 7(6):515-25. PubMed ID: 14599349
[TBL] [Abstract][Full Text] [Related]
3. A fluorescence lifetime based binding assay to characterize kinase inhibitors.
Lebakken CS; Hee Chol Kang ; Vogel KW
J Biomol Screen; 2007 Sep; 12(6):828-41. PubMed ID: 17644772
[TBL] [Abstract][Full Text] [Related]
4. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma.
Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P
J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360
[TBL] [Abstract][Full Text] [Related]
5. Development of a fluorescence polarization bead-based coupled assay to target different activity/conformation states of a protein kinase.
Lu Z; Yin Z; James L; Syto R; Stafford JM; Koseoglu S; Mayhood T; Myers J; Windsor W; Kirschmeier P; Samatar AA; Malcolm B; Turek-Etienne TC; Kumar CC
J Biomol Screen; 2004 Jun; 9(4):309-21. PubMed ID: 15191648
[TBL] [Abstract][Full Text] [Related]
6. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
[TBL] [Abstract][Full Text] [Related]
7. Homogeneous and nonradioactive high-throughput screening platform for the characterization of kinase inhibitors in cell lysates.
Guenat S; Rouleau N; Bielmann C; Bedard J; Maurer F; Allaman-Pillet N; Nicod P; Bielefeld-Sévigny M; Beckmann JS; Bonny C; Bossé R; Roduit R
J Biomol Screen; 2006 Dec; 11(8):1015-26. PubMed ID: 17092917
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence polarization competition immunoassay for tyrosine kinases.
Seethala R
Methods; 2000 Sep; 22(1):61-70. PubMed ID: 11020319
[TBL] [Abstract][Full Text] [Related]
9. Staurosporine-based binding assay for testing the affinity of compounds to protein kinases.
Iyer GH; Taslimi P; Pazhanisamy S
Anal Biochem; 2008 Feb; 373(2):197-206. PubMed ID: 18047825
[TBL] [Abstract][Full Text] [Related]
10. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
[TBL] [Abstract][Full Text] [Related]
12. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
[TBL] [Abstract][Full Text] [Related]
13. Three mechanistically distinct kinase assays compared: Measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors.
Kashem MA; Nelson RM; Yingling JD; Pullen SS; Prokopowicz AS; Jones JW; Wolak JP; Rogers GR; Morelock MM; Snow RJ; Homon CA; Jakes S
J Biomol Screen; 2007 Feb; 12(1):70-83. PubMed ID: 17166826
[TBL] [Abstract][Full Text] [Related]
14. Real-time protein kinase assay.
Sun H; Low KE; Woo S; Noble RL; Graham RJ; Connaughton SS; Gee MA; Lee LG
Anal Chem; 2005 Apr; 77(7):2043-9. PubMed ID: 15801736
[TBL] [Abstract][Full Text] [Related]
15. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.
Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW
J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence labels in kinases: a high-throughput kinase binding assay for the identification of DFG-out binding ligands.
Simard JR; Rauh D
Methods Mol Biol; 2012; 800():95-117. PubMed ID: 21964785
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a competitive AKT serine/threonine kinase fluorescence polarization assay using a product-specific anti-phospho-serine antibody.
Turek TC; Small EC; Bryant RW; Hill WA
Anal Biochem; 2001 Dec; 299(1):45-53. PubMed ID: 11726183
[TBL] [Abstract][Full Text] [Related]
18. Proteome-wide discovery of unknown ATP-binding proteins and kinase inhibitor target proteins using an ATP probe.
Adachi J; Kishida M; Watanabe S; Hashimoto Y; Fukamizu K; Tomonaga T
J Proteome Res; 2014 Dec; 13(12):5461-70. PubMed ID: 25230287
[TBL] [Abstract][Full Text] [Related]
19. A liquid chromatography/mass spectrometry-based method for the selection of ATP competitive kinase inhibitors.
Khandekar SS; Feng B; Yi T; Chen S; Laping N; Bramson N
J Biomol Screen; 2005 Aug; 10(5):447-55. PubMed ID: 16093554
[TBL] [Abstract][Full Text] [Related]
20. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
